Related Experiment Video
Updated: Aug 16, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
Published on: May 31, 2024
Visualizing drug efficacy in vivo
Zhang Weisheng1, Chen Min, David B West
1Xenogen Corporation, Alameda, CA 94501, USA. wzhang@xenogen.com
Abstract:
Many enzymes are therapeutic targets for drug discovery, whereas other enzymes are important for understanding drug metabolism and pharmacokinetics during compound testing in animals. Testing of drug efficacy and metabolism in an animal model requires the measurement of disease endpoints as well as assays of enzyme activity in specific tissues at selected time points during treatment. This requires the removal of tissue and biochemical assays. Techniques to noninvasively assess drug effects on enzyme activity using imaging technology would facilitate understanding of drug efficacy, pharmacokinetics, and drug metabolism. Using a commercially available cytochrome P-450 3A substrate whose oxidized product is a luciferase substrate, we show for the first time that cytochrome P-450 enzyme activity can be measured in vivo in real time by bioluminescent imaging. This imaging approach could be applicable to study drug effects on therapeutic target enzymes, as well as drug metabolism enzymes.
Insights
Researchers developed a novel bioluminescent imaging technique to measure cytochrome P-450 enzyme activity in real time within living animals. This noninvasive method advances drug discovery and metabolism studies.
Area of Science:
- Biochemistry
- Pharmacology
- Biotechnology
Background:
- Enzymes are crucial in drug discovery and metabolism studies.
- Current methods for assessing enzyme activity in animal models are invasive and time-consuming.
- Noninvasive imaging techniques are needed to monitor drug effects on enzyme activity.
Purpose of the Study:
- To develop and validate a noninvasive method for measuring enzyme activity in vivo.
- To demonstrate the real-time assessment of cytochrome P-450 enzyme activity using bioluminescent imaging.
Main Methods:
- Utilized a commercially available cytochrome P-450 3A substrate.
- The substrate's oxidized product serves as a luciferase substrate.
- Employed bioluminescent imaging to detect enzyme activity in real time.
Main Results:
- Successfully measured cytochrome P-450 enzyme activity in vivo using bioluminescent imaging.
- Demonstrated the capability for real-time monitoring of enzyme activity.
- Validated the noninvasive approach for assessing drug metabolism and efficacy.
Conclusions:
- Bioluminescent imaging offers a powerful noninvasive tool for studying enzyme activity in vivo.
- This technique can be applied to assess drug effects on both therapeutic target enzymes and drug metabolism enzymes.
- The method facilitates a deeper understanding of drug efficacy, pharmacokinetics, and metabolism.
More Related Videos
08:26Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
In Vitro Drug Release Testing: Overview, Development and Validation
Measurement of Bioavailability: Pharmacodynamic Methods
Modified-Release Drug Delivery Systems: Bioavailability